Preemptive Therapy vs Antiviral Prophylaxis and CMV in Seronegative Liver Transplant Recipients With Seropositive Donors

This randomized trial compares preemptive therapy vs antiviral prophylaxis with valganciclovir in cytomegalovirus (CMV)-seronegative liver transplant recipients with seropositive donors for the prevention of CMV disease.
Source: JAMA - Category: General Medicine Source Type: research